PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.86%
Revenue growth similar to TSM's 5.72%. Walter Schloss would see if both companies share industry tailwinds.
6.66%
Gross profit growth at 75-90% of TSM's 8.46%. Bill Ackman would demand operational improvements to match competitor gains.
7.80%
EBIT growth 1.25-1.5x TSM's 6.88%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
7.80%
Operating income growth 1.25-1.5x TSM's 6.88%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
9.06%
Net income growth above 1.5x TSM's 3.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
9.26%
EPS growth 1.25-1.5x TSM's 6.30%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
9.43%
Diluted EPS growth 1.25-1.5x TSM's 6.30%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.16%
Share count expansion well above TSM's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.16%
Diluted share count expanding well above TSM's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.16%
Dividend reduction while TSM stands at 10.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
61.61%
OCF growth above 1.5x TSM's 18.67%. David Dodd would confirm a clear edge in underlying cash generation.
121.34%
FCF growth above 1.5x TSM's 9.67%. David Dodd would verify if the firm’s strategic investments yield superior returns.
432.02%
10Y revenue/share CAGR 1.25-1.5x TSM's 318.30%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
210.95%
5Y revenue/share CAGR above 1.5x TSM's 67.13%. David Dodd would look for consistent product or market expansions fueling outperformance.
68.26%
3Y revenue/share CAGR 1.25-1.5x TSM's 51.25%. Bruce Berkowitz might see better product or regional expansions than the competitor.
348.22%
10Y OCF/share CAGR at 75-90% of TSM's 418.94%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
252.22%
5Y OCF/share CAGR above 1.5x TSM's 104.19%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
49.01%
3Y OCF/share CAGR under 50% of TSM's 99.71%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
700.06%
Net income/share CAGR above 1.5x TSM's 412.86% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
512.90%
5Y net income/share CAGR above 1.5x TSM's 65.92%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
27.59%
Below 50% of TSM's 62.08%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
400.49%
10Y equity/share CAGR above 1.5x TSM's 244.19%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
229.15%
5Y equity/share CAGR above 1.5x TSM's 59.54%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
121.37%
3Y equity/share CAGR above 1.5x TSM's 30.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
41.32%
Below 50% of TSM's 419456757.26%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
6.51%
Below 50% of TSM's 162064779.55%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-4.60%
Firm’s AR is declining while TSM shows 5.98%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.14%
Inventory growth well above TSM's 5.96%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.11%
Asset growth at 50-75% of TSM's 11.80%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
9.99%
BV/share growth above 1.5x TSM's 4.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.42%
Debt shrinking faster vs. TSM's 24.96%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
9.55%
R&D growth drastically higher vs. TSM's 4.45%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.33%
We cut SG&A while TSM invests at 45.03%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.